As October Rose breast cancer awareness campaigns begin in Belgium, medical researchers at the Institut Roi Albert II are testing personalized treatment methods and three-dimensional tumor replicas to avoid unnecessary heavy therapies, rtl.be reported. Oncologists at the Saint-Luc University Hospitals are screening patient blood samples to identify specific biological markers that reveal tumor aggressiveness and drug sensitivity.
Personalized Cancer Treatment Research at Saint-Luc University Hospitals
In a Saint-Luc laboratory, scientists examine blood samples to understand the distinct biology of each patient’s tumor. Cédric Van Marcke, an oncologist at the Institut Roi Albert II, stated that every patient has a particular cancer biology that explains both its aggressiveness and its sensitivity to various treatments. This biological profiling aims to pinpoint exactly which therapies will work for an individual patient.
Alongside blood analysis, researchers build organoids, which are three-dimensional miniatures of a patient’s tumor created in the laboratory using medical imaging. These models replicate the tumor and its immediate environment. Van Marcke noted that organoids allow the team to test different drugs and therapeutic strategies in the lab without exposing the patient directly to harsh side effects.
Funding Hurdles for Innovative Oncology Projects
Developing these advanced testing methods requires significant financial backing, yet securing grants for early-stage, highly innovative research remains difficult. François Duhoux, an oncologist at the Institut Roi Albert II, explained that public authorities and major funds typically finance ideas already supported by extensive preliminary data. When researchers pursue highly innovative approaches that need rapid advancement, they require supplementary private funds.
The Fondation Saint-Luc raises money specifically to support these experimental research programs. Among its prominent donors is René Beltjens, a Brussels entrepreneur who raised more than 570,000 euros through a cycling expedition. Beltjens undertook the fundraiser after his wife passed away from breast cancer, following a novel treatment that gave her four additional years of life. Beltjens stated that experiencing those four extra years when his children were between one and six years old was monumental, driving his commitment to fund scientific improvements that can offer similar outcomes to other families.
Post-Cancer Support and the Transition to Daily Life
While clinical research focuses on tumor profiling and lab-grown models, public advocacy groups emphasize the challenges patients face after active medical treatments end.
Frequently Asked Questions
What are tumor organoids and how do they help breast cancer patients?
Organoids are three-dimensional laboratory replicas of a patient’s tumor and its immediate environment built using medical imaging. According to Institut Roi Albert II oncologist Cédric Van Marcke, these models allow researchers to test various drugs and therapeutic strategies in vitro, sparing patients from enduring direct side effects during the trial phase.
How much money did René Beltjens raise for the Saint-Luc research fund?
Brussels entrepreneur René Beltjens raised more than 570,000 euros through a cycling expedition to support the breast cancer research program at the Institut Roi Albert II. Beltjens launched the fundraising effort after a novel treatment extended his late wife’s life by four years.
Why do innovative oncology research projects struggle to secure public grants?
Institut Roi Albert II oncologist François Duhoux stated that public authorities and large funding bodies typically direct capital toward ideas backed by extensive preliminary data. Consequently, highly innovative and experimental research tracks require supplementary private donations and foundations to advance quickly.